Michael Kremer: Investing in Vaccines Now Would Buy Time, Save $Billions
While vaccine manufacturing capacity is typically built only after clinical approval, Nobel Laureate, Michael Kremer, says building it during the clinical trials could advance vaccine distribution by 6 months or more. (HARVARD UNIVERSITY/UPI/Newscom)
Loading component...
Join Us on Every Major Platform
Loading component...
BEHIND THE MIC
Bruce Edwards
International Monetary Fund
Bruce Edwards produces the IMF podcast program. He's an award-winning audio producer and journalist who's covered armed conflicts, social unrest, and natural disasters from all corners of the world. He believes economists have an important role in solving the world's problems and aspires to showcase their research in every IMF podcast.
Rhoda Metcalfe
RHODA METCALFE is an independent journalist and audio producer.
